Bill Text: OH SCR10 | 2013-2014 | 130th General Assembly | Enrolled

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: To memorialize the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups.

Spectrum: Moderate Partisan Bill (Republican 52-17)

Status: (Engrossed - Dead) 2014-01-29 - Concurrence [SCR10 Detail]

Download: Ohio-2013-SCR10-Enrolled.html

---

As Adopted by the Senate

130th General Assembly Regular Session 2013-2014

S. C. R. No. 10

Senator Burke 

Cosponsors: Senators Brown, Gardner, Tavares, Bacon, Balderson, Beagle, Coley, Eklund, Faber, Hite, Hughes, Jones, Kearney, LaRose, Lehner, Manning, Obhof, Oelslager, Patton, Peterson, Sawyer, Schaffer, Seitz, Skindell, Smith, Uecker, Widener 

---

A CONCURRENT RESOLUTION

To memorialize the Congress of the United States to

1

seek the withdrawal of the United States

2

Preventive Services Task Force recommendation

3

against prostate-specific antigen-based screening

4

for prostate cancer for men in all age groups.

5

BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO
(THE HOUSE OF REPRESENTATIVES CONCURRING):

WHEREAS, The United States Preventive Services Task Force	6
(USPSTF) is an independent panel of nonfederal experts in	7
prevention and evidence-based medicine that is composed of primary	8
care physicians; and	9

WHEREAS, The USPSTF members are appointed by the United	10
States Department of Health and Human Services to conduct	11
scientific evidence reviews of a broad range of clinical health	12
care preventive services and develop recommendations for primary	13
care clinicians and health systems; and	14

WHEREAS, The USPSTF acknowledges that prostate cancer is the	15
most commonly diagnosed nonskin cancer in men in the United	16
States, with one in six American men being diagnosed with prostate	17
cancer in his lifetime; and	18

WHEREAS, Prostate cancer is the second leading cause of	19
cancer-related deaths in men in the United States; and	20

WHEREAS, The American Cancer Society estimates that in 2013	21
approximately 238,590 men in the United States will be diagnosed	22
with prostate cancer and 29,720 men will die from the disease; and	23

WHEREAS, In Ohio alone, there are approximately 7,961 newly	24
diagnosed cases of prostate cancer and 1,232 deaths from the	25
disease on an annual basis, according to the February 2011 report	26
issued by the Ohio Cancer Incidence Surveillance System; and	27

WHEREAS, In 2008, the USPSTF recommended against	28
prostate-specific antigen-based screening for prostate cancer for	29
men ages 75 and older; and	30

WHEREAS, In October 2011, the USPSTF issued a new	31
recommendation against prostate-specific antigen-based screening	32
for prostate cancer for men in all age groups, because it	33
concluded that there is moderate or high certainty that the	34
service has no net benefit or that the harms outweigh the	35
benefits; and	36

WHEREAS, The USPSTF states that the October 2011	37
recommendation applies to men in the United States who do not have	38
symptoms of prostate cancer, even though by the time a man	39
experiences symptoms of prostate cancer, the cancer is generally	40
too advanced to cure; and	41

WHEREAS, The USPSTF states that its recommendation against	42
screening applies regardless of race, even though the USPSTF	43
acknowledges that African-American men have a substantially higher	44
prostate cancer incidence rate than Caucasian men and more than	45
twice the prostate cancer mortality rate of Caucasian men; and	46

WHEREAS, The USPSTF issued this recommendation without having	47
a urologist or oncologist, two types of physicians who specialize	48
in diagnosing and treating patients with prostate cancer, on the	49
task force; and	50

WHEREAS, The USPSTF's 2011 recommendation regarding prostate	51
cancer screening follows its recommendation in November 2009	52
against routine mammograms for women ages 40 to 49 and against	53
teaching women to do breast self-examinations, which Congress	54
rejected after public outcry; and	55

WHEREAS, The most recently updated study, the Goteborg	56
Randomized Population-based Prostate Cancer Screening Trial, found	57
that with screening, deaths from prostate cancer dropped 44 per	58
cent over a 14-year period, compared with men who did not undergo	59
screening, and that prostate cancer screening efficiency was	60
similar to other cancers; and	61

WHEREAS, The USPSTF recommendation against screening puts	62
into harm's way men who are most at risk: the underinsured, those	63
who live in areas where health care is not readily available,	64
those who have a family history of prostate cancer, and	65
African-American men, who have a higher incidence of and higher	66
mortality rate from prostate cancer than Caucasian men; now	67
therefore be it	68

RESOLVED, That we, the members of the 130th General Assembly	69
of the State of Ohio, in adopting this resolution, respectfully	70
memorialize the Congress of the United States to seek the	71
withdrawal of the United States Preventive Services Task Force	72
recommendation against prostate-specific antigen-based screening	73
for prostate cancer for men in all age groups; and be it further	74

RESOLVED, That the Clerk of the Senate transmit duly	75
authenticated copies of this resolution to each member of the Ohio	76
Congressional delegation.	77